BackBioasis Technologies Overview

Bioasis Technologies Receivables

Bioasis Technologies's receivables is $14K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$13851.00
↓ 77.13% YoYΔ $-46702.00 vs prior year quarter

Peer trimmed avg / median

Loading

Bioasis Technologies Receivables History

Loading

Bioasis Technologies vs. peers: Receivables Comparison

Loading

Bioasis Technologies Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bioasis Technologies (BIOAF) FAQ

As of the most recent data (November 2022), BIOAF shows a receivables of $14K. That compares with $61K in the prior-year period — down 77.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOAF's receivables is now $14K (was $61K) — a 77.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bioasis Technologies is outperforming or lagging.

Tracking BIOAF's receivables over time shows whether Bioasis Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $14K That compares with $61K in the prior-year period — down 77.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Bioasis Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $14K) with ownership activity and broader fundamentals.

Bioasis Technologies's receivables is $14K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.